1988
DOI: 10.1002/art.1780310509
|View full text |Cite
|
Sign up to set email alerts
|

B cells expressing cd5 are increased in sjögren's syndrome

Abstract: In this investigation of B cells expressing the CD5 (Leu-1) cell surface marker, we found increased numbers of these cells in 13 of 19 patients with primary Sjiigren's syndrome (SS) (68%), as well as in the rheumatoid arthritis patients. The percentage of B cells that demonstrated increased expression of CD5 was 46% in SS patients, 47% in rheumatoid arthritis patients, 24% in systemic lupus erythematosus patients, and 26% in normal subjects. Over a 2-year period, CD5 expression on B cells was a stable finding … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

5
81
0
3

Year Published

1989
1989
2015
2015

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 211 publications
(89 citation statements)
references
References 24 publications
5
81
0
3
Order By: Relevance
“…The leukemic cells in CLL express the CD5 molecule and produce autoantibodies; the same subpopulation of B cells is found in increased numbers in peripheral blood and salivary gland samples from patients with primary SS (38-40). Interestingly, the percentage of these cells has been shown to be higher in primary SS patients with detectable monoclonal paraproteins than in those without (38), and remission of malignant lymphoma in some primary SS patients has been shown to be accompanied by restoration of CD5+ B cell levels to normal (39). Perhaps the lymphoproliferation in primary SS is highly selective and a distinct subpopulation of B cells, possibly those expressing the CD5 molecule, is selected and may be the same subpopulation of B cells involved in such other B cell neoplasms as Waldenstrom's macroglobulinemia, essential mixed cryoglobulinemia, and chronic lymphocytic leukemia.…”
Section: Discussionmentioning
confidence: 99%
“…The leukemic cells in CLL express the CD5 molecule and produce autoantibodies; the same subpopulation of B cells is found in increased numbers in peripheral blood and salivary gland samples from patients with primary SS (38-40). Interestingly, the percentage of these cells has been shown to be higher in primary SS patients with detectable monoclonal paraproteins than in those without (38), and remission of malignant lymphoma in some primary SS patients has been shown to be accompanied by restoration of CD5+ B cell levels to normal (39). Perhaps the lymphoproliferation in primary SS is highly selective and a distinct subpopulation of B cells, possibly those expressing the CD5 molecule, is selected and may be the same subpopulation of B cells involved in such other B cell neoplasms as Waldenstrom's macroglobulinemia, essential mixed cryoglobulinemia, and chronic lymphocytic leukemia.…”
Section: Discussionmentioning
confidence: 99%
“…9 Large numbers of B-1a cells were found in subjects with Sjö gren's syndrome or rheumatoid arthritis. [10][11][12] B-1a cells were also detected in gingival lesions of subjects with chronic periodontitis. 13 Periodontitis is an infectious disease that affects tooth-supporting structures such as connective tissue attachment and alveolar bone.…”
Section: Introductionmentioning
confidence: 93%
“…[3][4][5] Large numbers of B-1a cells were found in subjects with chronic periodontitis, Sjö gren's syndrome and rheumatoid arthritis. [6][7][8][9][10] Interleukin (IL)-10 is an important cytokine in the regulation of immune responses and was earlier considered to be mainly anti-inflammatory. IL-10 is currently, however, recognized as a pro-inflammatory cytokine that promotes a Th2 response as well as B-cell proliferation and antibody production.…”
Section: Introductionmentioning
confidence: 99%